PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9335229-7 1997 TNF-alpha production (measured by MTT/cytotoxic assay) by neutrophils was markedly increased in PRL-treated or pituitary-grafted rats in comparison to controls, whereas BRC treatment reduced TNF-alpha production. monooxyethylene trimethylolpropane tristearate 34-37 prolactin Rattus norvegicus 96-99 11448119-0 2001 Leukaemia inhibitory factor and interleukin 6 inhibit secretion of prolactin and growth hormone by rat pituitary MtT/SM cells. monooxyethylene trimethylolpropane tristearate 113-116 prolactin Rattus norvegicus 67-76 9152610-8 1997 In psp 6 specimen, in contrast, PRL suppressed the apoptotic reaction, increased the cell survival rate (MTT assay), and decreased the cell death rate (LDH assay). monooxyethylene trimethylolpropane tristearate 105-108 prolactin Rattus norvegicus 32-35 3777138-8 1986 Although transplantable pituitary MtT/W15 tumors secreted very large amounts of PRL, compared with pituitaries from DES-treated rats, rat prolactin mRNA as evaluated by mean grain counts was considerably less in the MtT/W15 tumor than in DES-treated pituitary cells. monooxyethylene trimethylolpropane tristearate 34-37 prolactin Rattus norvegicus 138-147 1734040-0 1992 Increased peptidylarginine deiminase expression during induction of prolactin biosynthesis in a growth-hormone-producing rat pituitary cell line, MtT/S. monooxyethylene trimethylolpropane tristearate 146-149 prolactin Rattus norvegicus 68-77 1734040-1 1992 Insulin and type I insulin-like growth factor (IGF-I) suppressed growth hormone (GH) expression followed by the induction of prolactin (PRL) biosynthesis in MtT/S cells cultured with normal sera. monooxyethylene trimethylolpropane tristearate 157-160 prolactin Rattus norvegicus 125-134 1625521-5 1992 During chronic severe hyperprolactinemia, induced by the growth of a MtT.W15 tumor, CSF PRL concentrations increased to 75 ng/ml, but this represented only 1.5% of serum PRL concentrations. monooxyethylene trimethylolpropane tristearate 69-72 prolactin Rattus norvegicus 88-91 1794611-1 1991 Insulin suppresses growth hormone expression and induces prolactin (PRL) biosynthesis in MtT/S cells cultured in a medium supplemented with normal sera. monooxyethylene trimethylolpropane tristearate 89-92 prolactin Rattus norvegicus 57-66 1794611-1 1991 Insulin suppresses growth hormone expression and induces prolactin (PRL) biosynthesis in MtT/S cells cultured in a medium supplemented with normal sera. monooxyethylene trimethylolpropane tristearate 89-92 prolactin Rattus norvegicus 68-71 1794611-7 1991 These results suggest that estrogen is required for the insulin-mediated induction of PRL biosynthesis in MtT/S cells. monooxyethylene trimethylolpropane tristearate 106-109 prolactin Rattus norvegicus 86-89 2208075-0 1990 Promoting action of prolactin released from a grafted transplantable pituitary tumor (MtT/F84) on rat prostate carcinogenesis. monooxyethylene trimethylolpropane tristearate 86-89 prolactin Rattus norvegicus 20-29 2602387-0 1989 Estrogen stimulates both prolactin and growth hormone mRNAs expression in the MtT/F4 transplantable pituitary tumor. monooxyethylene trimethylolpropane tristearate 78-81 prolactin Rattus norvegicus 25-34 2602387-3 1989 The expression of both PRL and growth hormone mRNA levels was increased in the MtT/F4 tumors. monooxyethylene trimethylolpropane tristearate 79-82 prolactin Rattus norvegicus 23-26 2602387-6 1989 E2 also stimulated both growth hormone and PRL mRNA expression in the MtT/F4 transplantable tumor. monooxyethylene trimethylolpropane tristearate 70-73 prolactin Rattus norvegicus 43-46 1731525-2 1992 Northern analysis showed increased PRL mRNA expression in estrogen-treated pituitary and in MtT/F4 and MtT/F-DMBA tumors. monooxyethylene trimethylolpropane tristearate 92-95 prolactin Rattus norvegicus 35-38 1731525-2 1992 Northern analysis showed increased PRL mRNA expression in estrogen-treated pituitary and in MtT/F4 and MtT/F-DMBA tumors. monooxyethylene trimethylolpropane tristearate 103-106 prolactin Rattus norvegicus 35-38 1731525-3 1992 Prolactin mRNA amounts in MtT/W15 tumor were decreased by estrogen treatment. monooxyethylene trimethylolpropane tristearate 26-29 prolactin Rattus norvegicus 0-9 2124415-4 1990 MtT/F-DMBA tumors expressed prolactin (PRL), growth hormone (GH), and adrenocorticotropin (ACTH) mRNAs. monooxyethylene trimethylolpropane tristearate 0-3 prolactin Rattus norvegicus 28-37 2124415-4 1990 MtT/F-DMBA tumors expressed prolactin (PRL), growth hormone (GH), and adrenocorticotropin (ACTH) mRNAs. monooxyethylene trimethylolpropane tristearate 0-3 prolactin Rattus norvegicus 39-42 2917354-3 1989 E17 beta (10(-7) M) caused a significant increase in PRL cell proliferation in normal pituitary [3.9 +/- 0.4 versus 7.7 +/- 0.9% (SEM) of immunostained PRL cells with thymidine incorporation] [P less than 0.01] but produced a significant decrease in PRL cell proliferation in MtT/W15 primary cell cultures [6.7 +/- 1.0 versus 3.7 +/- 0.8%] [P less than 0.05]. monooxyethylene trimethylolpropane tristearate 276-279 prolactin Rattus norvegicus 53-56 2917354-5 1989 There was a significant decrease in PRL mRNA and an increase in GH mRNA expression in cultured MtT/W15 tumor cells by immunocytochemistry and in situ hybridization analyses. monooxyethylene trimethylolpropane tristearate 95-98 prolactin Rattus norvegicus 36-39 2461092-1 1988 Estrogens inhibit tumor growth and modify PRL and GH expression in the MtT/W15 transplantable rat pituitary tumor. monooxyethylene trimethylolpropane tristearate 71-74 prolactin Rattus norvegicus 42-45 6409174-1 1983 Inoculation of cyclic female rats with the prolactin (Prl)/growth hormone-secreting pituitary tumor, MtT.W15, resulted in a cessation of estrous cyclicity within 5--10 days. monooxyethylene trimethylolpropane tristearate 101-104 prolactin Rattus norvegicus 43-52 6540621-2 1984 MtT SA5 tumor produces prolactin (PRL), growth hormone, and adrenocorticotropic hormone, and MtT SA6 tumor secretes PRL and growth hormone. monooxyethylene trimethylolpropane tristearate 0-3 prolactin Rattus norvegicus 34-37 6286280-1 1982 Male and female Wistar-Furth rats bearing the pituitary tumor MtT/W15 had serum GH and PRL levels several hundred-fold higher, and immunoreactive somatomedin levels 3-fold higher, than those of controls. monooxyethylene trimethylolpropane tristearate 62-65 prolactin Rattus norvegicus 87-90 15719-7 1977 In contrast, resection of MtT resulted in tumor regression, a fall to normal of serum prolactin, and a nearly 3-fold increase in prolactin binding. monooxyethylene trimethylolpropane tristearate 26-29 prolactin Rattus norvegicus 86-95 15719-7 1977 In contrast, resection of MtT resulted in tumor regression, a fall to normal of serum prolactin, and a nearly 3-fold increase in prolactin binding. monooxyethylene trimethylolpropane tristearate 26-29 prolactin Rattus norvegicus 129-138 190840-5 1977 The MtT/F4 tumour increased its secretion of GH in response to TRH, 10 mug/ml, and theophylline, but no effect was seen with lower concentrations of TRH or with SRIF; Prl secretion by the F4 tumour was increased by theophylline, but TRH and SRIF had no effect. monooxyethylene trimethylolpropane tristearate 4-7 prolactin Rattus norvegicus 167-170 28475602-8 2017 In addition, the MTT assay shows that PRL maintains normal mitochondrial activity even in neurons exposed to Glu. monooxyethylene trimethylolpropane tristearate 17-20 prolactin Rattus norvegicus 38-41